eISSN: 1896-9151
ISSN: 1734-1922
Archives of Medical Science
Current issue Archive Special issues Subscription
SCImago Journal & Country Rank

 
4/2005
vol. 1
 
Share:
Share:
more
 
 

SHORT COMMUNICATION
The lung function in operated acquired mitral and aortic valve diseases without left ventricular failure – preliminary observations before operation

Mirosław Bitner
,
Dariusz Nowak

Arch Med Sci 2005; 1, 4: 254-257
Online publish date: 2005/12/22
Article file
- The lung.pdf  [0.06 MB]
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
 
Introduction
Despite the different level and mechanisms of advanced acquired left heart valve diseases, all of them impede pulmonary vein outflow. Therefore the authors assume that their similar in this aspect haemodynamics influences the lung function in a similar way, and it should be visible in patients who required an operation. Optimally, a heart operation is performed before left ventricular failure develops. On the other hand, the lung function in left ventricular failure and chronic heart failure was previously investigated, but no consensus was reached [1-6]. Little is known about disturbances in the lung function of the patients required a heart operation, let alone how an operation on cardio-pulmonary by-pass influences the lung function. Our prospective randomized clinical study is designed to evaluate the influence of the operations on cardio-pulmonary by-pass particularly with systemic normothermia and cold crystalloid cardioplegia on the function of organs which are the most prone to damage during the procedure: mainly the heart and lungs. The study obtained approval of The Bioethics Committee of the Medical University.
This article presents the first part of investigation: the external respiratory function in the patients required heart operations for acquired mitral or aortic valve diseases without left ventricular failure. This was the start point for further investigations.

Material and methods
Between February 2002 and November 2004, 332 patients with acquired valve diseases (117 mitral, 215 aortic) were qualified for their first heart operation. The excluding criteria were strictly pursued (smokers, patients with pulmonary diseases; left ventricle, kidney, or liver insufficiency; stroke; inability to co-operate; obesity, to be operated on moderate hypothermia; emergency operations and re-operations), and the 27 non-smokers were randomly chosen. They were 21-78 (54.3±6) year old, 19 male, 8 female, 16 with aortic, and 11 with mitral valve diseases (Table I), with the left ventricular ejection fraction LVEF=55.6±6.5% (42-66%), 22 in NYHA class III, 5 – NYHA class IV. The informed consent was signed.
The heart function was evaluated by Doppler echocardiography (Ultrasonocardiograph HP Sonos 2000). The pulmonary function was assessed by means of the bodypletysmograph (Master Laboratory Screen, Jaeger Toennis, Wuerzburg, Germany) according to the American Thoracic Society (ATS) [7]. Data obtained from bodypletysmography (sitting position), spirometry, and examination of the diffusing capacity for carbon monoxide and Helium (single breath method, sitting and supine position) were analyzed and compared to respective data in the control group consisting of healthy volunteers, and with the ATS norms for the sitting position [7]. The following parameters of the lung function were measured during bodypletysmography and spirometry:
• ITGV – intrathoracic gas volume,
• ERV – expiratory reserve volume,
• RV – residual volume,
• VC IN – vital capacity,
• TLC – total lung capacity,
• RV%TLC – residual volume in % of total lung capacity,
• R tot – total airway resistance,
• R IN – inspiratory airway resistance,
• R EX – expiratory airway resistance,
• FVC – forced vital capacity,
• FEV1 – forced expiratory volume after 1 sec.,
• FEV1%FVC – FEV1 in % of FVC,
• FEV1%VC – FEV1 in % of VC,
• PEF – peak expiratory flow,
• FEF75 – forced expiratory flow at 75% of FVC,
• FEF50 – forced expiratory flow at 50% of FVC,
• FEF25 – forced expiratory flow at 25% of FVC.

During a single breath diffusion examination, the following parameters were measured with helium or carbon monoxide:
• RV-He – residual volume,
• TLC-He – total lung capacity,
• RV%TLC – RV in % of TLC,
• FRC He – functional residual capacity,
• FRC%TLC He – FRC in % of TLC,
• FIHe – inspiratory concentration He,
• FAHe – expiratory concentration He,
• TLCO SB – diffusion capacity, single breath,
• Hb – patients' hemoglobin,
• TLCOc – TLCO, patient' hemoglobin-corrected,
• VA – alveolar volume,
• TLCO/VA – TLCO per VA,
• TLCOc/VA – TLCO, patient' hemoglobin-corrected per VA,
• BSA – body surface area,
• TLCO/BSA – diffusion capacity, BSA-corrected,
• TLCOc/BSA – TLCO, patient' hemoglobin and BSA-corrected,
• FICO – inspiratory concentration CO,
• FACO – expiratory concentration CO,
• TLC – VCIN (from previous spirometry measurement) + RV (from current TLCO-SB).

The statistical analysis was made by means of the commercially available program „Statistica” with appropriate tests (non parametric Wilcoxon-Mann-Whitney's, and Wilcoxon signed rank tests for this part of the study).

Results
Bodypletysmography, spirometry and diffusion data of the control group did not differ statistically from the norms given by the ATS. The following patients' data values were significantly worse than in the control group (Table II): from bodypletysmography (in the sitting position): Vital Capacity in % actual/predicted; from spirometry (sitting and supine positions): Forced Vital Capacity in % actual/predicted, % average/normal Alveolar Volume; from diffusion (sitting and supine positions): % average/normal Total Lung Diffusing Capacity for Carbon Monoxide standardized for Hemoglobin, average Total Lung Diffusing Capacity for Carbon Monoxide standardized for Hemoglobin and Body Surface Area, and % average/normal Total Lung Capacity for Helium. Interestingly, % av./N TLCOc/VA was insignificantly lower in the patients' group. There were similarities connected with changing the position from sitting to supine in both groups as follows (Table III): a similar significant rise in % av./N TLCOc (<0.05), and in % av./N TLCOc/VA (p<0.001); a similar significant fall in % av./N VA (p<0.01), % av./N TLC He (p<0.01 vs p<0.001), % av./N Functional Residual Capacity He (% av./N FRC He, p<0.001 vs p<0.01), and % av./N FRC % TLC He (p<0.001 vs p<0.01). There were two differences: in the patients group a significant fall in av./N RV % TLC He, and absence of a significant fall in % av./N RV He (Table III).

Discussion
The authors proved their presumption that advanced left heart valve diseases influence the pulmonary function before left ventricle insufficiency develops. At this state of the diseases required operation the impeded pulmonary veins outflow causes restrictive pulmonary changes (significantly worse values of VC, FVC, TLC, VA, and TLCO in the patients than in the control group). These changes, although significant, are less than 30% of the predicted values, therefore are considered to be mild.
Hitherto the studies investigated the pulmonary function in patients with chronic heart or left ventricular failure for different reasons, in a retrospective way, and with different excluding/including criteria [1-5]. Therefore their results and conclusions are different, ranging from normal throughout restrictive, to restrictive combined with obstructive changes. Similar remarks refer for studies considering the lung function connected with postural changes [6]. In our patients, respiratory adaptation to the supine position was essentially unaffected (Table III).
Conclusions: In the patients requiring an operation for acquired valve diseases without left ventricular failure, associated lung function disturbances are present. These are mild restrictive changes, including diminished Total Lung Diffusing Capacity (mainly membrane related), whereas adaptation to the supine position remains essentially unaffected.

Acknowledgment
The authors thank Malgorzata Misztal, PhD for the statistical analysis.

The study from the range of research numbered 502-11-818, Medical University of Lodz.
References
1. Johnson BD, Beck KC, Olson LJ, O'Malley KA, Allison TG, et al. Pulmonary function in patients with reduced left ventricular function: influence of smoking and cardiac surgery. Chest 2001; 120: 1869-76.
2. Ricart S, Casan P, Bellido-Casado J, Gonzalez M, Cotes C, et al. Lung function in cardiac dysfunction [Spanish]. Arch Bronconeumol 2004; 40: 62-6.
3. Zamarron Sanz C, del Campo Matias F, Amaro Cendon A, Salgueiro Rodriguez M, Rodriguez Suarez JR. Pulmonary diffusion of carbon monoxide in patients with mitral stenosis [Spanish]. An Med Interna 2002; 19: 66-8.
4. Chang SC, Chang HI, Liu SY, Shiao GM, Perng RP. Effects of body position and age on membrane diffusing capacity and pulmonary capillary blood volume. Chest 1992; 102: 139-42.
5. Nanas S, Nanas J, Papazachou O, Kassiotis C, Papamichalopoulos A, et al. Resting lung function and hemodynamic parameters as predictors of exercise capacity in patients with chronic heart failure. Chest 2003; 123: 1386-93.
6. Faggiano P, D'Aloia A, Simoni P, Gualeni A, Foglio K, et al. Effects of body position on the carbon monoxide diffusing capacity in patients with chronic heart failure: relation to hemodynamic changes. Cardiology 1998; 89: 1-7.
7. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152: 1107-36.
Copyright: © 2005 Termedia & Banach. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe